PDGF-C: A new performer in the neurovascular interplay

Trends in Molecular Medicine

Volumn 19, Issue 8, 2013, Pages 474-486

  Lee, Chunsik ^a   Zhang, Fan ^a,b   Tang, Zhongshu ^a   Liu, Yizhi ^a   Li, Xuri ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Angiogenesis; Neuroprotection; Neurovascular crosstalk; PDGF C; Survival

Indexed keywords

PLATELET DERIVED GROWTH FACTOR C; VASCULOTROPIN;

ASTROCYTE; BINDING AFFINITY; BLOOD VESSEL; CARDIOVASCULAR SYSTEM; CELLS; DEGENERATIVE DISEASE; DISEASES; ENDOTHELIUM CELL; FIBROBLAST; GENE DELETION; GLIA CELL; GROWTH; HEALTH; HUMAN; MACROPHAGE; MATURATION; MONOCYTE; NERVE CELL; NONHUMAN; OLIGODENDROGLIA; PERICYTE; PHENOTYPE; PROTEIN EXPRESSION; RECEPTOR BINDING; REVIEW; SURVIVAL; VASCULAR SMOOTH MUSCLE;

EID: 84881023573     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2013.04.006     Document Type: Review

References (116)

1. Li X., et al. PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor. Nat. Cell Biol. 2000, 2:302-309.
2. Kazlauskas A. A new member of an old family. Nat. Cell Biol. 2000, 2:E78-E79.
3. Su E.J., et al. Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nat. Med. 2008, 14:731-737.
4. Rieckmann P. Imatinib buys time for brain after stroke. Nat. Med. 2008, 14:712-713.
5. Tang Z., et al. Survival effect of PDGF-CC rescues neurons from apoptosis in both brain and retina by regulating GSK3beta phosphorylation. J. Exp. Med. 2010, 207:867-880.
6. Cao R., et al. Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-αα and -αβ receptors. FASEB J. 2002, 16:1575-1583.
7. Crawford Y., et al. PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment. Cancer Cell 2009, 15:21-34.
8. Campbell J.S., et al. Targeting stromal cells for the treatment of platelet-derived growth factor C-induced hepatocellular carcinogenesis. Differentiation 2007, 75:843-852.
9. Li X., et al. Revascularization of ischemic tissues by PDGF-CC via effects on endothelial cells and their progenitors. J. Clin. Invest. 2005, 115:118-127.
10. Hou X., et al. PDGF-CC blockade inhibits pathological angiogenesis by acting on multiple cellular and molecular targets. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:12216-12221.
11. di Tomaso E., et al. PDGF-C induces maturation of blood vessels in a model of glioblastoma and attenuates the response to anti-VEGF treatment. PLoS ONE 2009, 4:e5123.
12. Anderberg C., et al. Paracrine signaling by platelet-derived growth factor-CC promotes tumor growth by recruitment of cancer-associated fibroblasts. Cancer Res. 2009, 69:369-378.
13. Li H., et al. PDGF-D is a potent transforming and angiogenic growth factor. Oncogene 2003, 22:1501-1510.
14. Li X., et al. VEGF-independent angiogenic pathways induced by PDGF-C. Oncotarget 2010, 1:309-314.
15. Ding H., et al. A specific requirement for PDGF-C in palate formation and PDGFR-α signaling. Nat. Genet. 2004, 36:1111-1116.
16. Ruiz de Almodovar C., et al. VEGF mediates commissural axon chemoattraction through its receptor Flk1. Neuron 2011, 70:966-978.
17. Feng Y., et al. Crosstalk in the retinal neurovascular unit - lessons for the diabetic retina. Exp. Clin. Endocrinol. Diabetes 2012, 120:199-201.
18. Quaegebeur A., et al. The neurovascular link in health and disease: molecular mechanisms and therapeutic implications. Neuron 2011, 71:406-424.
19. Lander C., et al. Neurons produce a neuronal cell surface-associated chondroitin sulfate proteoglycan. J. Neurosci. 1998, 18:174-183.
20. Howell M.D., Gottschall P.E. Lectican proteoglycans, their cleaving metalloproteinases, and plasticity in the central nervous system extracellular microenvironment. Neuroscience 2012, 217:6-18.
21. Ola M.S., et al. Neurodegeneration and neuroprotection in diabetic retinopathy. Int. J. Mol. Sci. 2013, 14:2559-2572.
22. Storkebaum E., et al. Cerebrovascular disorders: molecular insights and therapeutic opportunities. Nat. Neurosci. 2011, 14:1390-1397.
23. Ito M., et al. Transplanted bone marrow stromal cells protect neurovascular units and ameliorate brain damage in stroke-prone spontaneously hypertensive rats. Neuropathology 2012, 32:522-533.
24. Hamilton N.B., et al. Pericyte-mediated regulation of capillary diameter: a component of neurovascular coupling in health and disease. Front. Neuroenerget. 2010, 2:5.
25. Kur J., et al. Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease. Prog. Retin Eye Res. 2012, 31:377-406.
26. Dirnagl U. Pathobiology of injury after stroke: the neurovascular unit and beyond. Ann. N. Y. Acad. Sci. 2012, 126:21-25.
27. Tao R.R., et al. Targeting nitrosative stress for neurovascular protection: new implications in brain diseases. Curr. Drug Targets 2012, 13:272-284.
28. Paul D., et al. Serum factor requirements of normal and simian virus 40-transformed 3T3 mouse fibroplasts. Proc. Natl. Acad. Sci. U.S.A. 1971, 68:645-652.
29. Heldin C.H., et al. Partial purification and characterization of platelet factors stimulating the multiplication of normal human glial cells. Exp. Cell Res. 1977, 109:429-437.
30. Bergsten E., et al. PDGF-D is a specific, protease-activated ligand for the PDGF β-receptor. Nat. Cell Biol. 2001, 3:512-516.
31. LaRochelle W.J., et al. PDGF-D, a new protease-activated growth factor. Nat. Cell Biol. 2001, 3:517-521.
32. Gilbertson D.G., et al. Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF α and β receptor. J. Biol. Chem. 2001, 276:27406-27414.
33. Karvinen H., et al. PDGF-C and -D and their receptors PDGFR-α and PDGFR-β in atherosclerotic human arteries. Eur. J. Clin. Invest. 2009, 39:320-327.
34. Uutela M., et al. Chromosomal location, exon structure, and vascular expression patterns of the human PDGFC and PDGFD genes. Circulation 2001, 103:2242-2247.
35. Midgley V.C., Khachigian L.M. Fibroblast growth factor-2 induction of platelet-derived growth factor-C chain transcription in vascular smooth muscle cells is ERK-dependent but not JNK-dependent and mediated by Egr-1. J. Biol. Chem. 2004, 279:40289-40295.
36. Sanchez-Guerrero E., et al. Angiotensin II induction of PDGF-C expression is mediated by AT1 receptor-dependent Egr-1 transactivation. Nucleic Acids Res. 2008, 36:1941-1951.
37. Wagsater D., et al. Effects of PDGF-C and PDGF-D on monocyte migration and MMP-2 and MMP-9 expression. Atherosclerosis 2009, 202:415-423.
38. Lei H., et al. A potential role for PDGF-C in experimental and clinical proliferative vitreoretinopathy. Invest. Ophthalmol. Vis. Sci. 2007, 48:2335-2342.
39. Hamada T., et al. The expression of SCDGF/PDGF-C/fallotein and SCDGF-B/PDGF-D in the rat central nervous system. Mech. Dev. 2002, 112:161-164.
40. Lee Y.W., et al. Expression of platelet-derived growth factor in the developing cochlea of rats. Acta Otolaryngol. 2004, 124:558-562.
41. Runne H., et al. Dysregulation of gene expression in primary neuron models of Huntington's disease shows that polyglutamine-related effects on the striatal transcriptome may not be dependent on brain circuitry. J. Neurosci. 2008, 28:9723-9731.
42. Oumesmar B.N., et al. Developmental expression of platelet-derived growth factor α-receptor in neurons and glial cells of the mouse CNS. J. Neurosci. 1997, 17:125-139.
43. Kruk J.S., et al. 5-HT(1A) receptors transactivate the platelet-derived growth factor receptor type β in neuronal cells. Cell. Signal. 2013, 25:133-143.
44. Smits A., et al. Neurotrophic activity of platelet-derived growth factor (PDGF): rat neuronal cells possess functional PDGF β-type receptors and respond to PDGF. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:8159-8163.
45. Kanamoto T., et al. Platelet-derived growth factor receptor α is associated with oxidative stress-induced retinal cell death. Curr. Eye Res. 2011, 36:336-340.
46. Pan J.Z., et al. Rat brain DNA transcript profile of halothane and isoflurane exposure. Pharmacogenet. Genomics 2006, 16:171-182.
47. Ishii Y., et al. Characterization of neuroprogenitor cells expressing the PDGF β-receptor within the subventricular zone of postnatal mice. Mol. Cell. Neurosci. 2008, 37:507-518.
48. Biswas S.K., et al. PDGF- and insulin/IGF-1-specific distinct modes of class IA PI 3-kinase activation in normal rat retinas and RGC-5 retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 2008, 49:3687-3689.
49. Ishii Y., et al. Mouse brains deficient in neuronal PDGF receptor-β develop normally but are vulnerable to injury. J. Neurochem. 2006, 98:588-600.
50. Renner O., et al. Time- and cell type-specific induction of platelet-derived growth factor receptor-β during cerebral ischemia. Brain Res. Mol. Brain Res. 2003, 113:44-51.
51. Morioka I., et al. PDGF-α receptor expression following hypoxic-ischemic injury in the neonatal rat brain. Kobe J. Med. Sci. 2004, 50:21-30.
52. Boor P., et al. PDGF-C mediates glomerular capillary repair. Am. J. Pathol. 2010, 177:58-69.
53. Wilkinson-Berka J.L., et al. Inhibition of platelet-derived growth factor promotes pericyte loss and angiogenesis in ischemic retinopathy. Am. J. Pathol. 2004, 164:1263-1273.
54. Itoh Y., et al. Astrocytes and pericytes cooperatively maintain a capillary-like structure composed of endothelial cells on gel matrix. Brain Res. 2011, 1406:74-83.
55. Fredriksson L., et al. Platelet-derived growth factor C deficiency in C57BL/6 mice leads to abnormal cerebral vascularization, loss of neuroependymal integrity, and ventricular abnormalities. Am. J. Pathol. 2012, 180:1136-1144.
56. Raines S.M., et al. Loss of PDGF-B activity increases hepatic vascular permeability and enhances insulin sensitivity. Am. J. Physiol. Endocrinol. Metab. 2011, 301:E517-E526.
57. Armulik A., et al. Pericytes regulate the blood-brain barrier. Nature 2010, 468:557-561.
58. Bell R.D., et al. Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron 2010, 68:409-427.
59. Zymek P., et al. The role of platelet-derived growth factor signaling in healing myocardial infarcts. J. Am. Coll. Cardiol. 2006, 48:2315-2323.
60. Liu Y., et al. The molecular cloning of platelet-derived growth factor-C (PDGF-C) gene of Gekko japonicus and its expression change in the spinal cord after tail amputation. Cell. Mol. Neurobiol. 2008, 29:263-271.
61. Fruttiger M., et al. Platelet-derived growth factor is constitutively secreted from neuronal cell bodies but not from axons. Curr. Biol. 2000, 10:1283-1286.
62. Murtie J.C., et al. PDGF and FGF2 pathways regulate distinct oligodendrocyte lineage responses in experimental demyelination with spontaneous remyelination. Neurobiol. Dis. 2005, 19:171-182.
63. Jiang L., et al. Oligogenesis and oligodendrocyte progenitor maturation vary in different brain regions and partially correlate with local angiogenesis after ischemic stroke. Transl. Stroke Res. 2011, 2:366-375.
64. Woodruff R.H., et al. Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination. Mol. Cell. Neurosci. 2004, 25:252-262.
65. Rascher G., et al. Extracellular matrix and the blood-brain barrier in glioblastoma multiforme: spatial segregation of tenascin and agrin. Acta Neuropathol. 2002, 104:85-91.
66. Bonner J.C. Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth Factor Rev. 2004, 15:255-273.
67. Campbell J.S., et al. Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:3389-3394.
68. Lai K.K., et al. Extracellular matrix dynamics in hepatocarcinogenesis: a comparative proteomics study of PDGFC transgenic and Pten null mouse models. PLoS Genet. 2011, 7:e1002147.
69. Tuuminen R., et al. PDGF-A, -C, and -D but not PDGF-B increase TGF-β1 and chronic rejection in rat cardiac allografts. Arterioscler. Thromb. Vasc. Biol. 2009, 29:691-698.
70. Ponten A., et al. Transgenic overexpression of platelet-derived growth factor-C in the mouse heart induces cardiac fibrosis, hypertrophy, and dilated cardiomyopathy. Am. J. Pathol. 2003, 163:673-682.
71. Zhuo Y., et al. Over-expression of PDGF-C using a lung specific promoter results in abnormal lung development. Transgenic Res. 2006, 15:543-555.
72. Biswas S.K., et al. Imatinib induces apoptosis by inhibiting PDGF- but not insulin-induced PI 3-kinase/Akt survival signaling in RGC-5 retinal ganglion cells. Mol. Vis. 2009, 15:1599-1610.
73. Roder C., et al. Polymorphisms in TGFB1 and PDGFRB are associated with Moyamoya disease in European patients. Acta Neurochir. (Wien) 2010, 152:2153-2160.
74. Kang H.S., et al. Plasma matrix metalloproteinases, cytokines and angiogenic factors in Moyamoya disease. J. Neurol. Neurosurg. Psychiatry 2010, 81:673-678.
75. Bai Y., et al. A functional variant in promoter region of platelet-derived growth factor-D is probably associated with intracerebral hemorrhage. J. Neuroinflammation 2012, 9:26.
76. Greenberg J.I., et al. A role for VEGF as a negative regulator of pericyte function and vessel maturation. Nature 2008, 456:809-813.
77. Pennock S., Kazlauskas A. Vascular endothelial growth factor A competitively inhibits platelet-derived growth factor (PDGF)-dependent activation of PDGF receptor and subsequent signaling events and cellular responses. Mol. Cell. Biol. 2012, 32:1955-1966.
78. Banfi A., et al. Therapeutic angiogenesis due to balanced single-vector delivery of VEGF and PDGF-BB. FASEB J. 2012, 26:2486-2497.
79. Mackenzie F., Ruhrberg C. Diverse roles for VEGF-A in the nervous system. Development 2012, 139:1371-1380.
80. Jurek A., et al. Platelet-derived growth factor-induced signaling pathways interconnect to regulate the temporal pattern of Erk1/2 phosphorylation. Cell. Signal. 2011, 23:280-287.
81. Sun Z., et al. VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd. J. Exp. Med. 2012, 209:1363-1377.
82. Simons M. An inside view: VEGF receptor trafficking and signaling. Physiology (Bethesda) 2012, 27:213-222.
83. Peng F., et al. Platelet-derived growth factor CC-mediated neuroprotection against HIV Tat involves TRPC-mediated inactivation of GSK 3β. PLoS ONE 2012, 7:e47572.
84. Eitner F., et al. PDGF-C is a proinflammatory cytokine that mediates renal interstitial fibrosis. J. Am. Soc. Nephrol. 2008, 19:281-289.
85. Wu X., Ding H. Generation of conditional knockout alleles for PDGF-C. Genesis 2007, 45:653-657.
86. Fretto L.J., et al. Mechanism of platelet-derived growth factor (PDGF) AA, AB, and BB binding to α and β PDGF receptor. J. Biol. Chem. 1993, 268:3625-3631.
87. Kelly J.D., et al. Platelet-derived growth factor (PDGF) stimulates PDGF receptor subunit dimerization and intersubunit trans-phosphorylation. J. Biol. Chem. 1991, 266:8987-8992.
88. Andrae J., et al. Role of platelet-derived growth factors in physiology and medicine. Genes Dev. 2008, 22:1276-1312.
89. Fiedler J., et al. To go or not to go: migration of human mesenchymal progenitor cells stimulated by isoforms of PDGF. J. Cell. Biochem. 2004, 93:990-998.
90. Nazarenko I., et al. PDGF and PDGF receptors in glioma. Ups. J. Med. Sci. 2012, 117:99-112.
91. Ostendorf T., et al. The PDGF family in renal fibrosis. Pediatr. Nephrol. 2012, 27:1041-1050.
92. Huang J.S., et al. Human platelet-derived growth factor: radioimmunoassay and discovery of a specific plasma-binding protein. J. Cell Biol. 1983, 97:383-388.
93. Basciani S., et al. Platelet-derived growth factor receptor β-subtype regulates proliferation and migration of gonocytes. Endocrinology 2008, 149:6226-6235.
94. Borkham-Kamphorst E., et al. Pro-fibrogenic potential of PDGF-D in liver fibrosis. J. Hepatol. 2007, 46:1064-1074.
95. Kowarik M., et al. Platelet-derived growth factor (PDGF) and PDGF receptor expression and function in folliculostellate pituitary cells. Exp. Clin. Endocrinol. Diabetes 2010, 118:113-120.
96. Buetow B.S., et al. Platelet-derived growth factor B-chain of hematopoietic origin is not necessary for granulation tissue formation and its absence enhances vascularization. Am. J. Pathol. 2001, 159:1869-1876.
97. Furuhashi M., et al. Platelet-derived growth factor production by B16 melanoma cells leads to increased pericyte abundance in tumors and an associated increase in tumor growth rate. Cancer Res. 2004, 64:2725-2733.
98. Foss B., et al. Platelet-derived growth factor (PDGF) in human acute myelogenous leukemia: PDGF receptor expression, endogenous PDGF release and responsiveness to exogenous PDGF isoforms by in vitro cultured acute myelogenous leukemia blasts. Eur. J. Haematol. 2001, 66:365-376.
99. Li L., et al. Differential effects of imatinib on PDGF-induced proliferation and PDGF receptor signaling in human arterial and venous smooth muscle cells. J. Cell. Biochem. 2006, 99:1553-1563.
100. Yamamoto M., et al. A strategy for developing effective amyotropic lateral sclerosis pharmacotherapy: from clinical trials to novel pharmacotherapeutic strategies. Expert Opin. Pharmacother. 2008, 9:1845-1857.
101. Xaymardan M., et al. Platelet-derived growth factor-AB promotes the generation of adult bone marrow-derived cardiac myocytes. Circ. Res. 2004, 94:E39-E45.
102. Chen C.P., et al. Lycopene binding compromised PDGF-AA/-AB signaling and migration in smooth muscle cells and fibroblasts: prediction of the possible lycopene binding site within PDGF. Naunyn Schmiedebergs Arch. Pharmacol. 2010, 381:401-414.
103. Yamamoto S., et al. Platelet-derived growth factor receptor regulates salivary gland morphogenesis via fibroblast growth factor expression. J. Biol. Chem. 2008, 283:23139-23149.
104. Wirz S., et al. Influence of platelet-derived growth factor-AB on tissue development in autologous platelet-rich plasma gels. Tissue Eng. Part A 2011, 17:1891-1899.
105. Musa H., et al. Inhibition of platelet-derived growth factor-AB signaling prevents electromechanical remodeling of adult atrial myocytes that contact myofibroblasts. Heart Rhythm 2013, 10.1016/j.hrthm.2013.03.014.
106. Tsirakis G., et al. Role of platelet-derived growth factor-AB in tumour growth and angiogenesis in relation with other angiogenic cytokines in multiple myeloma. Hematol. Oncol. 2012, 30:131-136.
107. Chen S.J., et al. Enrichment and fluorescence enhancement of adenosine using aptamer-gold nanoparticles, PDGF aptamer, and Oligreen. Talanta 2010, 81:493-498.
108. Lokker N.A., et al. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors. Cancer Res. 2002, 62:3729-3735.
109. Conley-LaComb M.K., et al. PTEN regulates PDGF ligand switch for β-PDGFR signaling in prostate cancer. Am. J. Pathol. 2012, 180:1017-1027.
110. Gondi C.S., et al. Human umbilical cord blood stem cells show PDGF-D-dependent glioma cell tropism in vitro and in vivo. Neuro Oncol. 2010, 12:453-465.
111. Huang W., et al. A novel function for platelet-derived growth factor D: induction of osteoclastic differentiation for intraosseous tumor growth. Oncogene 2012, 31:4527-4535.
112. Hudkins K.L., et al. Exogenous PDGF-D is a potent mesangial cell mitogen and causes a severe mesangial proliferative glomerulopathy. J. Am. Soc. Nephrol. 2004, 15:286-298.
113. Ponten A., et al. Platelet-derived growth factor D induces cardiac fibrosis and proliferation of vascular smooth muscle cells in heart-specific transgenic mice. Circ. Res. 2005, 97:1036-1045.
114. Liu M.Y., et al. Inducible platelet-derived growth factor D-chain expression by angiotensin II and hydrogen peroxide involves transcriptional regulation by Ets-1 and Sp1. Blood 2006, 107:2322-2329.
115. Wang Z., et al. Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-κB signaling. Cancer Res. 2007, 67:11377-11385.
116. Ehnman M., et al. Distinct effects of ligand-induced PDGFRα and PDGFRβ signaling in the human rhabdomyosarcoma tumor cell and stroma cell compartments. Cancer Res. 2013, 73:2139-2149.